June 12, 2023 07:16 AM EDTUpdated 10:44 AM
Pharma
Manufacturing

No­vo Nordisk ups in­vest­ment in Den­mark API man­u­fac­tur­ing fa­cil­i­ty to $2.3B

Katherine Lewin

News Reporter

Amid on­go­ing short­ages of some of its most pop­u­lar drugs, No­vo Nordisk said it is in­vest­ing $2.3 bil­lion (15.9 bil­lion Dan­ish kro­ner) to­tal to ex­pand …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times